The effect of aloe vera capsules on itching in hemodialysis patients

Investigating the effect of aloe vera capsules on the rash of hemodialysis patients in Arak

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191104045328N13

Enrollment

Registered

2022-12-18

Start date

2022-12-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus. Other pruritus

Interventions

Intervention 1: Intervention group: In addition to routine medicines, the patient is given aloe vera capsules containing 100 mg of aloe vera product twice a day (at 8 am and 8 pm) in the first week. F

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent to enter the study Age more than 18 years There is no other reason for itching such as liver disease or allergy or skin disease. Ensuring the accuracy of dialysis patients Patients diagnosed with chronic renal failure Equal number of dialysis sessions per week

Exclusion criteria

Exclusion criteria: History of itchy skin diseases Taking pruritus drugs Pregnancy or liver disorders Hemodialysis for less than 6 months

Design outcomes

Primary

Measure	Time frame
Intensity of pruritus. Timepoint: Before and after the intervention. Method of measurement: Visual analogue scale of pruritus intensity.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Naser Saidi

Arak University of Medical Sciences

nassersaidi@yahoo.com+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026